Clinical trial
To Determine Long Term Efficacy and Safety of Asenapine in Schizophrenic Patient…
NCT00150176 · Organon and Co, Industry · Completed
Key facts
| NCT number | NCT00150176 |
|---|---|
| Title | To Determine Long Term Efficacy and Safety of Asenapine in Schizophrenic Patient Population (A7501012)(COMPLETED)(P05770) |
| Official title | A Randomized, Placebo-Controlled, Double-Blind Trial of Asenapine in the Prevention of Relapse After Long-Term Treatment of Schizophrenia |
| Lead sponsor | Organon and Co, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Schizophrenia |
| Intervention type | Drug |
| Interventions | Asenapine - Open Label, Placebo - Double Blind, Asenapine - Double Blind |
| Enrollment | 831 |
| Start date | Apr 1, 2005 |
| Primary completion | Jun 1, 2008 |
| Completion | Jul 1, 2008 |
| First posted | Sep 8, 2005 |
| Last update posted | Feb 8, 2022 |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: